CHRISTINA BALDWIN: Open Payments
NPI 1982983011 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,473 in 12 payments from 6 companies in 2025. Trend: 2023 $6,361 · 2024 $4,130 · 2025 $2,473
Consulting: $2,187Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $2,274 |
| AstraZeneca Pharmaceuticals LP | 2 | $90 |
| Incyte Corporation | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Adaptive Biotechnologies Corporation | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: VENCLEXTA, MONJUVI, SCEMBLIX, CALQUENCE, EPKINLY, clonoSEQ, LYNOZYFIC.
Industry payments across NY — which companies pay providers there.
